全文获取类型
收费全文 | 44751篇 |
免费 | 3210篇 |
国内免费 | 2868篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 542篇 |
妇产科学 | 205篇 |
基础医学 | 2959篇 |
口腔科学 | 43篇 |
临床医学 | 5372篇 |
内科学 | 11867篇 |
皮肤病学 | 191篇 |
神经病学 | 795篇 |
特种医学 | 4572篇 |
外国民族医学 | 5篇 |
外科学 | 9087篇 |
综合类 | 5662篇 |
现状与发展 | 2篇 |
预防医学 | 1618篇 |
眼科学 | 128篇 |
药学 | 3511篇 |
18篇 | |
中国医学 | 1438篇 |
肿瘤学 | 2769篇 |
出版年
2024年 | 58篇 |
2023年 | 590篇 |
2022年 | 1319篇 |
2021年 | 1614篇 |
2020年 | 1493篇 |
2019年 | 1295篇 |
2018年 | 1291篇 |
2017年 | 1206篇 |
2016年 | 1454篇 |
2015年 | 1639篇 |
2014年 | 3026篇 |
2013年 | 2696篇 |
2012年 | 2746篇 |
2011年 | 2824篇 |
2010年 | 2586篇 |
2009年 | 2694篇 |
2008年 | 2711篇 |
2007年 | 2627篇 |
2006年 | 2554篇 |
2005年 | 2102篇 |
2004年 | 1540篇 |
2003年 | 1367篇 |
2002年 | 1197篇 |
2001年 | 1078篇 |
2000年 | 924篇 |
1999年 | 748篇 |
1998年 | 651篇 |
1997年 | 623篇 |
1996年 | 517篇 |
1995年 | 493篇 |
1994年 | 474篇 |
1993年 | 346篇 |
1992年 | 310篇 |
1991年 | 222篇 |
1990年 | 208篇 |
1989年 | 198篇 |
1988年 | 177篇 |
1987年 | 126篇 |
1986年 | 112篇 |
1985年 | 143篇 |
1984年 | 106篇 |
1983年 | 63篇 |
1982年 | 89篇 |
1981年 | 98篇 |
1980年 | 72篇 |
1979年 | 63篇 |
1978年 | 71篇 |
1977年 | 64篇 |
1976年 | 52篇 |
1975年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
以我所统一标准,确诊为“肝阳上亢证”者,进行微循环观察,肝阳上亢证者90例;阴虚阳上亢证者88例,健康对照组48例。观察发现肝阳上亢组与健康对照组及阴虚阳亢组与健康对照组均有显著性差异。通过卡方证明本检测数据可靠,微循环观测可作为“肝阳上亢证”的客观检测指标之一。 相似文献
102.
成人斯蒂尔病的肝损害 总被引:3,自引:0,他引:3
目的;探讨成人斯蒂尔病(adult-onset Stil's disease,AOSD))合并肝损害的发生、表现、治疗和预后。方法;对27例成人斯蒂尔病患者中出现肝损害的13例,根据病情轻重采用中药水剂茵陈蒿汤中味或益肝灵片加服联苯双酯滴丸、强力宁注射液进行治疗。结果:11例(84.6%)肝功能恢复正常,1例好转,1例因急性肝功能衰竭死亡。结论:成人斯蒂尔病患者合并肝损害甚为常见。经中药和西药联合应用合理治疗后多数患者可恢复或好转。应重视和警惕发生危及生命和急性肝功能衰竭。 相似文献
103.
金丹肝泰1号对大鼠急性肝损伤防治作用的实验研究 总被引:2,自引:0,他引:2
用D-氨基半乳糖(D-GaIN)制备大鼠急性肝损伤模型。方法:检测血清丙氨酸氨基转氨酶(ALT)和血清天门冬氨酸氨基转氨酶(AST)的活性,观察光镜下肝组织的病理学改变,探讨对急性肝损伤的保护作用。结果:口服浸膏可显降低急性肝损伤大鼠血清ALT和AST水平,减轻肝细胞的变性坏死,其作用强度与肝炎宁相当,但弱于联苯双酯。 相似文献
104.
Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation 总被引:1,自引:0,他引:1
T. Propst Albert Propst Karin Nachbaur I. Graziadei Hans Willeit Raimund Margreiter Wolfgang Vogel 《Transplant international》1997,10(3):234-237
It is well known that hepatitis C virus (HCV)-related chronic liver disease may be associated with various immunological
disorders including mixed cryoglobulinemia, which is accompanied by cutaneous vasculitis, arthralgias, membranoproliferative
glomerulonephritis, and neuropathy in association with cryoprecipitable immune complexes in serum. We describe here the first
case of central nervous system HCV infection with evidence of the virus in the cerebrospinal fluid in association with cryoglobulinemia
in a patient who developed recurrent episodes of papillitis and vasculitis of the arteria spinalis anterior after liver transplantation.
Received: 3 September 1996 Received after revision: 13 November 1996 Accepted: 6 December 1996 相似文献
105.
A rat model of monitoring liver allograft rejection 总被引:5,自引:0,他引:5
Timi Martelius Heikki Mäkisalo Krister Höckerstedt Eero Taskinen Irmeli Lautenschlager 《Transplant international》1997,10(2):103-108
Rat models are often used to study liver allograft rejection. We have established a model for rat liver allograft rejection,
monitored by fine needle aspiration biopsy (FNAB), in the strain combination PVG-to-BN with a mean survival time of 37 ± 20
days. In this model, we observed acute rejection with an intense peak of lymphoid blasts and lymphocyte-dominated inflammation
in the FNAB [9.1 ± 3.0 corrected increment units (CIU)], and an eventual increase in macrophages (up to 4.2 ± 4.4 CIU), together
with fibrosis and parenchymal necrosis in the graft. Markers of immune activation, such as an increase in IL-2-receptor (from
1 % ± 2 % to 21 % ± 13 %) and class II (from 20 % ± 9 % to 43 % ± 13 %) expressing lymphoid cells and induction of ICAM-1
in the graft, were consistent with the overall cellular response. The FNAB correlated well with parallel graft histology.
In this rat model, the atraumatic monitoring makes a close follow-up possible without having to sacrifice the experimental
animals. This saves work, animals, and costs in the study of liver rejection.
Received: 2 July 1996 Accepted: 28 October 1996 相似文献
106.
P. E. Wallemacq Raymond Reding Etienne M. Sokal Jean Ville de Goyet Stéphane Clement de Clety Véronique Van Leeuw Marc De Backer Jean-Bernard Otte 《Transplant international》1997,10(6):466-470
Pediatric liver transplant recipients constitute a population characterized by a particularly unpredictable and poor bioavailability
of cyclosporin (CyA). Even though several adult studies show that the new oral formulation of CyA, Neoral (NEO), produces
better bioavailability and blood level predictability, few data describe its pharmacokinetics in children. We performed a
complete analysis of the pharmacokinetics of NEO in ten small children after primary liver transplantation. Three pharmacokinetic
profiles were set up with data obtained from tests taken during i. v. administration of CyA, after the first oral NEO dose,
and after the last NEO dose before discharge from the hospital. The mean half-lives obtained were 8.1, 7.7, and 6.9 h, respectively,
and the bioavailabilities were 22 % and 21 % for the first and last NEO doses. A large interpatient variability was observed.
This was due, in part, to episodes of diarrhea that interfered with the pharmacokinetic evaluation and, in part, to the variability
of post-transplant hepatic function. There was a good correlation between CyA trough levels and their related AUCs for both
NEO profiles (r = 0.93 and r = 0.74, respectively). We conclude that, even though the pediatric OLT population remains more unpredictable than that of
adults, NEO has a relatively rapid half-life and a remarkably improved bioavailability.
Received: 29 November 1996 Received after revision: 10 April 1997 Accepted: 15 May 1997 相似文献
107.
J. Friedrich Massimo Malago Reinhard Lange Josef Kemnitz Filip Danninger Jochen Erhard 《Transplant international》1997,10(3):245-246
We report on the successful regrafting of a transplanted liver. The donor liver was first grafted into a patient suffering
from cryptogenic cirrhosis; the patient died 1 day after the elective transplantation of cerebral bleeding. The well-functioning
graft was harvested again and transferred to our institution. After another 12 h of cold ischemia, the liver was reperfused
in an urgently registered patient with recurrence of hepatitis B in his first graft. The transplantation was successfully
performed and the patient is now doing well, more than 5 months after regrafting with the reused liver.
Received: 21 October 1996 Received after revision: 9 January 1997 Accepted: 27 January 1997 相似文献
108.
T. Scholz Ø. Mathisen A. Bergan S. Osnes R. Innes T. Pedersen A. O. Aasen O. Søreide 《Transplant international》1997,10(3):180-184
We have introduced and evaluated several modifications of the conventional venovenous bypass (VVBP) in 29 adult patients
undergoing liver transplantation (OLT). A percutaneous technique for insertion of a jugular venous return cannula and a femoral
vein cannula was applied. The inferior mesenteric vein (IMV) was used for splanchnic decompression, which facilitated dissection
of the recipient liver and allowed portal anastomosis to be performed without disconnecting the portal bypass. A heat exchanger
was introduced into the bypass circuit to prevent heat loss. The percutaneous technique prevented complications related to
dissection in the axilla and groin. Hemodynamic characteristics corresponded to those found using the traditional technique.
Complications related to the VVBP were seen in only one patient in whom the femoral catheter was accidentally introduced into
the femoral artery. We conclude that percutaneous cannulas, use of the IMV for splanchnic decompression and the introduction
of a heat exchanger offer significant benefits and that they are safe and reliable.
Received: 23 August 1996 Received after revision: 14 January 1997 Accepted: 27 January 1997 相似文献
109.
Abstract One hundred eighty-one consecutive patients with fulminant hepatic failure (FHF) presenting in a 2-year period were reviewed. In this cohort we examined the impact of pretransplant renal failure on mortality and morbidity following orthotopic liver transplantation (OLTx). Twenty-seven patients (18 female, 9 male) with a median age of 43.5 years (range 19–65 years) underwent OLTx. FHF was due to idiosyncratic drug reaction ( n = 4), paracetamol overdose ( n = 3), seronegative hepatitis ( n = 17), hepatitis B ( n = 1), veno-occlusive disease ( n = 1), and Wilson's disease ( n = 1). Renal failure was present in 14 patients, 7 of whom died (whereas there was 100 % survival in patients without renal failure). Pretransplant renal failure was associated with prolonged mechanical ventilation (13 days vs 6 days, P = 0.05), prolonged intensive care stay (17 days vs 8 days, P - 0.01) and prolonged hospital stay (27 vs 21 days, P = NS). Pretransplant renal failure did not predict renal dysfunction at 1 year after OLTx. We conclude that the survival of patients transplanted for FHF is inferior to that of patients transplanted for chronic liver disease (67 % vs 88 % 1-year survival in Birmingham). For patients with FHF undergoing transplantation, pretransplant renal failure strongly predicts poor outcome with significantly greater consumption of resources. 相似文献
110.
研究深低温停循环(DHCA)与逆行脑灌注(RCP)时脑组织自由基的变化。健康杂种犬14只,随机等分为DHCA组和RCP组,在停循环前(A点)、DHCA/RCP30分(B点)、DHCA/RCP60分(C点)DHCA/RCP90分(D眯)和复温再灌注30分(E点)取脑皮层lg,检测丙二醛(MDA)和超氧化物歧化酶(SOD)水平。结果见两组在A点MDA和SOD无差别。在B、C、D、E点,DHCA组MDA 相似文献